Cite

HARVARD Citation

    Barrera, B. et al. (2023). Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis. Annals of clinical and translational neurology. 10 (4), pp. 579-588. [Online]. 
  
Back to record